Concepedia

Megan Riley

MR

Statistics

Publications

4

Citations

118

H-Index

4

Active since

2020

Affiliations

GlaxoSmithKline (Belgium)(Current)

University of Colorado Anschutz Medical Campus

Duke University Hospital

Geriatric Research Education and Clinical Center

Duke Medical Center

Megan Riley is an author at GlaxoSmithKline (Belgium) specializing in age-specific efficacy, vaccine efficacy, and vaccine safety.

ORCID

Publications per year

2020–2024

4

Publications

4

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals

Desmond Curran, Joon H. Kim, Sean Matthews et al. · Journal of the American Geriatrics Society · 2020 · 55 citations · Full text

, , +17

A label-free optical biosensor-based point-of-care test for the rapid detection of Monkeypox virus

Mete Aslan, Elif Seymour, Howard Brickner et al. · Biosensors and Bioelectronics · 2024 · 27 citations · Full text

, , +17

The adjuvanted recombinant zoster vaccine co-administered with the 13-valent pneumococcal conjugate vaccine in adults aged ≥50 years: A randomized trial

Ji-Young Min, Agnes Mwakingwe-Omari, Megan Riley et al. · Journal of Infection · 2021 · 19 citations · Full text

, , +17

Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults

Kenneth E. Schmader, Myron J. Levin, Michael Chen et al. · The Journals of Gerontology Series A · 2020 · 17 citations · Full text

, , +17

1–4 of 4